Australia: MAXIGEN BIOTECH Owns Trademark for 'MBI' and 'DOT ATOP RECTANGLE,DIVIDED IS LTR I'

Australia, June 23 -- MAXIGEN BIOTECH Inc., owns the trademark (2603684) for 'MBI' and 'DOT ATOP RECTANGLE,DIVIDED IS LTR I' till Nov. 13, 2035.

Status: registered: Registered/protected

Class: 10 [ophthalmometers; ophthalmic apparatus; surgical instruments and apparatus; eye testing apparatus; eye massage apparatus; eye drop guides; eye droppers for medical use; eye wash cups for medical purposes; bone substitutes for surgical use; hypodermic syringes; syringes for medical purposes; injection needles; spinal syringes; biodegradable bone fixation implants; bone void fillers comprised of artificial materials; bone void fillers consisting of artificial materials; bone prostheses; receptacles for applying medicines; robotic exoskeleton suits for medical purposes; cooling patches for medical purposes; bone implants made from artificial materials; suture materials; surgical implants comprised of artificial materials; surgical implants made of artificial materials; dental braces; dental apparatus and instruments; dental implants [prostheses]; facial aesthetic treatment apparatus using ultrasonic waves, other than facial steamers; medical apparatus and instruments; devices for injecting pharmaceuticals]

Type of Mark: Figurative

Date of Acceptance: Jan. 6

Registration Advertised: June 22

For further details contact Charles Cheung.

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2603684.

Disclaimer: Curated by HT Syndication.